Upgrade to SI Premium - Free Trial

Truist Securities Reiterates Eli Lilly (LLY) at Buy on Foundayo approval, 'remain bullish on Lilly'

April 1, 2026 12:53 PM
Truist Securities analyst Srikripa Devarakonda reiterated a Buy rating and $1,281.00 price target on Eli Lilly (NYSE: LLY).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments